peroxynitrous acid has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antel, J; Brück, W; Jack, C; Kuhlmann, T | 1 |
| Koito, H; Li, J; Peng, J; Ramenaden, ER; Rosenberg, PA; Volpe, JJ | 1 |
2 other study(ies) available for peroxynitrous acid and Demyelinating Diseases
| Article | Year |
|---|---|
Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis.
Topics: Astrocytes; Cell Death; Cells, Cultured; Demyelinating Diseases; Humans; Macrophages; Multiple Sclerosis; Myelin Sheath; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Oligodendroglia; Peroxynitrous Acid; Tyrosine | 2007 |
Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present.
Topics: Animals; Astrocytes; Cell Communication; Cell Death; Cell Differentiation; Cells, Cultured; Coculture Techniques; Demyelinating Diseases; Encephalitis; Gliosis; Inflammation Mediators; Lipopolysaccharides; Mice; Mice, Knockout; Microglia; NADPH Oxidases; Oligodendroglia; Peroxynitrous Acid; Rats; Signal Transduction; Tumor Necrosis Factor-alpha | 2008 |